Dr. Hong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Blossom St
Radiation Oncology
Boston, MA 02114Phone+1 617-726-6050Fax+1 617-726-3603
Summary
- Dr. Theodore Hong is a radiation oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital, Emerson Hospital, and Newton-Wellesley Hospital. He received his medical degree from University of Connecticut School of Medicine and has been in practice 17 years. He specializes in gastrointestinal cancer.
Education & Training
- University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 2001 - 2005
- University of Wisconsin Hospitals and ClinicsInternship, Internal Medicine, 2000 - 2001
- Uconn School Of MedicineClass of 2000
Certifications & Licensure
- MA State Medical License 2005 - 2025
- ME State Medical License 2020 - 2025
- NH State Medical License 2021 - 2025
- RI State Medical License 2020 - 2022
- WI State Medical License 2004 - 2009
- American Board of Radiology Radiation Oncology
Clinical Trials
- Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer Start of enrollment: 2007 Dec 01
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases Start of enrollment: 2003 Jun 01
- Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiotherapy.Nina N Sanford, Amol K Narang, Todd A Aguilera, Michael F Bassetti, Michael D Chuong
International Journal of Radiation Oncology, Biology, Physics. 2024-11-05 - 2 citationsSpatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment.Carina Shiau, Jingyi Cao, Dennis Gong, Mark T Gregory, Nicholas J Caldwell
Nature Genetics. 2024-11-01 - Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.Grace Lee, Daniel W Kim, Alicia C Smart, Nora K Horick, Christine E Eyler
American Journal of Clinical Oncology. 2024-08-01
Journal Articles
- Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic CancerHarvey J Mamon, Paul L Nguyen, Theodore S Hong, Aparna Parikh, Jennifer Y Wo, Rinaa S Punglia, Cristina Ferrone, Ryan D Nipp, Annals of Surgical Oncology
Lectures
- A pilot study of durvalumab/tremelimumab (durva/treme) and radiation (XRT) for metastatic biliary tract cancer (mBTC): Preliminary safety and efficacy.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Against - Debate: This House Believes FLOT Is the Standard Treatment for Fit Patients With T3N1 GEJ...ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Pre/Post-Operative Chemo-Radiation2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Join now to see all
Press Mentions
- Understanding Stage 4 Esophageal CancerNovember 15th, 2024
- IntraOp® Announces First Patient Enrolled in PACER Trial for Pancreatic CancerMay 9th, 2019
- Failure Is Not an OptionSeptember 17th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: